BLISSGVS

Bliss GVS Pharma Shareholding Pattern

₹682.00+0.82%
Market cap
₹7,215 crore
P/E
53.0
P/B
6.05
ROE
11.5%
Dividend yield
0.15%

As of 30-JUN-2026, promoters held 35.01% of Bliss GVS Pharma (-0.35 pp from 31-MAR-2026), foreign institutional investors 8.07%, domestic institutions 9.47% and the public 47.45%.

Bliss GVS Pharma shareholding pattern

Percentage of shares held, by quarter, newest first.

Bliss GVS Pharma shareholding by category (% of equity)
Holder30-JUN-202631-MAR-202631-DEC-202530-SEP-202530-JUN-202531-MAR-2025Change
Promoters35.01%35.36%35.36%35.39%35.44%n/a-0.35 pp
Foreign institutions (FII/FPI)8.07%10.45%14.54%13.27%12.65%n/a-2.38 pp
Domestic institutions (DII)9.47%5.04%5.78%5.98%6.54%n/a+4.43 pp
Public47.45%49.15%44.32%45.36%45.36%n/a-1.70 pp

Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.

Bliss GVS Pharma shareholding pattern — frequently asked questions

What is the promoter holding in Bliss GVS Pharma?

Promoters held 35.01% of Bliss GVS Pharma as of 30-JUN-2026, down 0.35 pp from 35.36% in 31-MAR-2026.

How much do FIIs hold in Bliss GVS Pharma?

Foreign institutional investors held 8.07% of Bliss GVS Pharma as of 30-JUN-2026, a change of -2.38 pp from the previous quarter.

How much do domestic institutions hold in Bliss GVS Pharma?

Domestic institutional investors, including mutual funds and insurers, held 9.47% of Bliss GVS Pharma as of 30-JUN-2026 (+4.43 pp from the previous quarter).

Who owns Bliss GVS Pharma?

As of 30-JUN-2026, Bliss GVS Pharma's shareholders were promoters (35.01%), foreign institutional investors 8.07%, domestic institutions 9.47% and the public 47.45%, as filed with the stock exchanges.

Same Data For Peers

💡 LearnHow to read a shareholding pattern →

Trade Bliss GVS Pharma With ATS

Track BLISSGVS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Bliss GVS Pharma share priceOpen a demat account →Brokerage calculator

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.